![](https://www.diabetesnews.com/wp-content/uploads/2012/05/No_Dead_Space_Insulin_Syringes_28g_29g-150x150.jpg)
Novo Nordisk UK has announced that insulin degludec (brand name Tresiba(R)), a new oncedaily basal insulin for adult patients with type 1 and type 2 diabetes, is available in the UK as a new treatment option.
Read more
Novo Nordisk UK has announced that insulin degludec (brand name Tresiba(R)), a new oncedaily basal insulin for adult patients with type 1 and type 2 diabetes, is available in the UK as a new treatment option.
Read more